Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine
Reference108 articles.
1. CAR T cell therapy: inroads to response and resistance;Brown;Nat. Rev. Immunol.,2019
2. Clinical lessons learned from the first leg of the CAR T cell journey;Majzner;Nat. Med.,2019
3. Approved CAR T cell therapies: ice bucket challenges on glaring safety risks and long-term impacts;Zheng;Drug Discov. Today,2018
4. Paving the way towards universal treatment with allogenic T cells;Townsend;Immunol. Res.,2020
5. Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma;Graham;Leukemia,2021
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent updates on allogeneic CAR-T cells in hematological malignancies;Cancer Cell International;2024-09-03
2. Advances in manufacturing chimeric antigen receptor immune cell therapies;Seminars in Immunopathology;2024-08-16
3. Unlocking T cell exhaustion: Insights and implications for CAR-T cell therapy;Acta Pharmaceutica Sinica B;2024-08
4. PELI2 regulates early B-cell progenitor differentiation and related leukemia via the IL-7R expression;HAEMATOLOGICA;2024
5. BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma;Journal of Nanobiotechnology;2024-05-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3